Sale!

Porphobilinogen PBG Qualitative Urine Test

820 د.إ

-10%

The Porphobilinogen (PBG) Qualitative Urine Test is a specialized diagnostic procedure designed to detect abnormal levels of PBG in the urine, which is a critical indicator for various types of porphyria. Porphyrias are a group of rare inherited or acquired disorders of certain enzymes in the heme biosynthesis pathway, leading to a buildup of natural chemicals that produce porphyrin in the body. Elevated levels of PBG in urine can signal an acute attack of porphyria, making this test crucial for the diagnosis and management of the condition.

Performed at DNA Labs UAE, a reputable facility known for its comprehensive range of diagnostic services, the PBG Qualitative Urine Test is conducted by collecting a urine sample from the patient. This sample is then analyzed using sophisticated laboratory techniques to detect the presence and concentration of porphobilinogen. The results from this test can provide essential information for the diagnosis, treatment planning, and monitoring of individuals suspected of having or known to have porphyria.

The cost of the Porphobilinogen Qualitative Urine Test at DNA Labs UAE is 820 AED. Given the specialized nature of this test and its importance in diagnosing potentially serious conditions, it represents a critical investment in one’s health for individuals showing symptoms or with a family history of porphyria. It is always recommended to consult with a healthcare provider to understand the need for this test and its implications fully.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PORPHOBILINOGEN PBG QUALITATIVE URINE Test

Test Details:

The Porphobilinogen (PBG) Qualitative Urine Test is a diagnostic test used to detect the presence of porphobilinogen in the urine. Porphobilinogen is an intermediate compound in the heme synthesis pathway, and its accumulation can be indicative of certain porphyrias, a group of rare genetic disorders that affect the production of heme.

During the test, a urine sample is collected from the patient and analyzed in the laboratory. The urine is mixed with a reagent that reacts with porphobilinogen, producing a characteristic color change. The intensity of the color change is then compared to a standard color chart to determine the presence and concentration of porphobilinogen in the urine.

A positive result indicates the presence of porphobilinogen in the urine, suggesting a possible diagnosis of acute intermittent porphyria (AIP) or other related porphyrias. A negative result indicates the absence of porphobilinogen and may rule out these conditions.

It is important to note that the PBG Qualitative Urine Test is a screening test and does not provide a definitive diagnosis. Further confirmatory tests, such as the measurement of porphobilinogen deaminase activity or genetic testing, may be required to confirm the diagnosis of a specific porphyria.

Test Components and Price:

  • Test Name: PORPHOBILINOGEN PBG QUALITATIVE URINE Test
  • Components: Column Chromatography
  • Price: 820.0 AED

Sample Condition:

10 mL (5 mL min.) aliquot of random urine collected in a dark coloured vial/container wrapped completely with black paper or aluminium foil. Ship refrigerated or frozen. Uncovered vials exposed to light are unacceptable.

Report Delivery:

Sample: Tue / Fri by 9 am

Report: Same day

Test Type and Doctor:

Test Type: Porphyria

Doctor: Physician

Test Department:

BIOPHYSICS

Pre Test Information:

Collect urine in a dark coloured vial/container wrapped completely with black paper or aluminium foil.

Symptoms and Diagnosis:

The PBG Qualitative Urine Test is typically ordered when a patient presents with symptoms suggestive of a porphyria, such as abdominal pain, neuropathy, and skin photosensitivity. It may also be used for monitoring the effectiveness of treatment in patients with known porphyria.

It is essential to consult with a healthcare provider or a specialist in metabolic disorders to interpret the test results accurately and determine the appropriate course of action based on the patient’s clinical presentation and medical history.

Test Name PORPHOBILINOGEN PBG QUALITATIVE URINE Test
Components
Price 820.0 AED
Sample Condition 10 mL (5 mL min.) aliquot of random urinecollectedinadarkcolouredvial\/ container wrapped completely with black paper or aluminium foil. Ship refrigeratedor frozen. Uncovered vials exposed to light are unacceptable.
Report Delivery SampleTue / Fri by 9 am;Report Same day
Method Column Chromatography
Test type Porphyria
Doctor Physician
Test Department: BIOPHYSICS
Pre Test Information Collect urine in a darkcolouredvial/ container wrapped completely with black paper or aluminium foil.
Test Details

The Porphobilinogen (PBG) Qualitative Urine Test is a diagnostic test used to detect the presence of porphobilinogen in the urine. Porphobilinogen is an intermediate compound in the heme synthesis pathway, and its accumulation can be indicative of certain porphyrias, a group of rare genetic disorders that affect the production of heme.

During the test, a urine sample is collected from the patient and analyzed in the laboratory. The urine is mixed with a reagent that reacts with porphobilinogen, producing a characteristic color change. The intensity of the color change is then compared to a standard color chart to determine the presence and concentration of porphobilinogen in the urine.

A positive result indicates the presence of porphobilinogen in the urine, suggesting a possible diagnosis of acute intermittent porphyria (AIP) or other related porphyrias. A negative result indicates the absence of porphobilinogen and may rule out these conditions.

It is important to note that the PBG Qualitative Urine Test is a screening test and does not provide a definitive diagnosis. Further confirmatory tests, such as the measurement of porphobilinogen deaminase activity or genetic testing, may be required to confirm the diagnosis of a specific porphyria.

The test is typically ordered when a patient presents with symptoms suggestive of a porphyria, such as abdominal pain, neuropathy, and skin photosensitivity. It may also be used for monitoring the effectiveness of treatment in patients with known porphyria.

It is essential to consult with a healthcare provider or a specialist in metabolic disorders to interpret the test results accurately and determine the appropriate course of action based on the patient’s clinical presentation and medical history.